Colo-rectal Cancer Clinical Trials

29 recruiting

Colo-rectal Cancer Trials at a Glance

30 actively recruiting trials for colo-rectal cancer are listed on ClinicalTrialsFinder across 6 cities in 12 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Boston, Grand Rapids, and Basingstoke. Lead sponsors running colo-rectal cancer studies include Imperial College London, Second Affiliated Hospital of Guangzhou Medical University, and Centre Hospitalier Universitaire de Saint Etienne.

Browse colo-rectal cancer trials by phase

Treatments under study

About Colo-rectal Cancer Clinical Trials

Looking for clinical trials for Colo-rectal Cancer? There are currently 29 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Colo-rectal Cancer trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Colo-rectal Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 30 trials

Recruiting

Clinicopathological Characteristics of Colon Cancer in Young Age

Colo-rectal CancerMolecular Pathway Deregulation
Seoul National University Bundang Hospital1,400 enrolled1 locationNCT05365412
Recruiting
Phase 1

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

Head and Neck CancerHNSCCColo-rectal Cancer+4 more
ALX Oncology Inc.170 enrolled7 locationsNCT07085091
Recruiting

Shield Post-Approval Study Protocol

Colo-rectal Cancer
Guardant Health, Inc.3,375 enrolled56 locationsNCT06880055
Recruiting

A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer Risks

Breast CancerOvarian CancerColo-rectal Cancer+2 more
Fondazione del Piemonte per l'Oncologia850 enrolled1 locationNCT07469709
Recruiting

Neoadjuvant Therapy With Tislelizumab for dMMR/MSI-H Stage II-III Colorectal Cancer

Colo-rectal Cancer (dMMR/MSI-H CRC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences30 enrolled1 locationNCT07352280
Recruiting
Phase 1Phase 2

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

Breast CancerProstate Cancer Castration-resistant Prostate CancerColo-rectal Cancer+2 more
MBrace Therapeutics150 enrolled7 locationsNCT07145255
Recruiting
Phase 3

Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial

Prostate CancerLung CancerColo-rectal Cancer+1 more
Roswell Park Cancer Institute800 enrolled1 locationNCT06563388
Recruiting
Not Applicable

The AIDPRO-CRC Trial

Colo-rectal Cancer
Zealand University Hospital1,200 enrolled7 locationsNCT06645015
Recruiting

Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)

Colo-rectal Cancer
Natera, Inc.25,000 enrolled1 locationNCT07046585
Recruiting
Not Applicable

Evaluation of SINGLE PORT (SP) Robotic Technology in Colorectal Surgery

Colo-rectal CancerRectal ProlapseColostomy Stoma+1 more
University of California, Davis25 enrolled1 locationNCT05321134
Recruiting
Not Applicable

Compare the Patient Satisfaction and Effectiveness After Novel Application-based or Conventional Health Education of Bowel Preparation for Colonoscopy

Colo-rectal CancerColon Lesion
National Taiwan University Hospital252 enrolled1 locationNCT06560671
Recruiting
Not Applicable

Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study

Colo-rectal Cancer
Massachusetts General Hospital2 enrolled4 locationsNCT05524428
Recruiting
Not Applicable

The Effect of the Training Program Given to Permanent Colostomy Patients on Self-efficacy

Colo-rectal CancerStoma Colostomy
Cukurova University70 enrolled1 locationNCT06905925
Recruiting

Colorectal Analysis for Signature Cancer Assessment Using Delta-HLD

Colo-rectal Cancer
Epiliquid Holding, Inc600 enrolled1 locationNCT07148297
Recruiting
Phase 2

Low-dose Trifluridine/Tipiracil With Bevacizumab in mCRC

Colo-rectal CancerBevacizumabThird-line and Beyond Therapy+1 more
Ruijin Hospital50 enrolled2 locationsNCT07085169
Recruiting
Phase 2

Phase Ⅱ Clinical Trial of Cadonilimab Combined With Anti-angiogenic Agents in Metastatic dMMR/MSI-H CRC

Colo-rectal CancerMSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers
Fudan University40 enrolled1 locationNCT07003022
Recruiting
Phase 3

tislelizUMaB in canceR Patients With molEcuLar residuaL Disease

Soft Tissue SarcomaLung CancerCancer+2 more
Gustave Roussy, Cancer Campus, Grand Paris717 enrolled1 locationNCT06332274
Recruiting

Early-Onset Colorectal Cancer: An Observational Retrospective and Prospective Multicenter Study

Colo-rectal Cancer
Niguarda Hospital20 enrolled1 locationNCT06965335
Recruiting
Phase 2

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

MelanomaHead and Neck Squamous Cell CarcinomaColo-rectal Cancer
Vyriad, Inc.87 enrolled27 locationsNCT04291105
Recruiting

Advanced Endo-therapeutic Procedure : Registry-based Observational Study

Colo-rectal CancerZenker DiverticulumPolyp of Colon
Centre hospitalier de l'Université de Montréal (CHUM)500 enrolled1 locationNCT04117100